2m 2m 2m 2m 2m 2m 2m
PROCEPT BIOROBOT (PRCT)
NASDAQ
$20.88+$0.28 (+1.36%)
Price as of Jun 23, 2026 7:58 PM EDT- $1.2BMarket Cap
- -64.15%1-Year Change
- Medical DevicesIndustry
PROCEPT BIOROBOT (PRCT)
$20.88+$0.28 (+1.36%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 308.1M +37.22% | 224.5M +64.84% | 136.2M +81.55% | 75.0M +117.60% | |
Cost of Revenue | 111.8M +27.95% | 87.4M +34.17% | 65.1M +71.75% | 37.9M +103.83% | |
Gross Profit | 196.2M +43.13% | 137.1M +92.96% | 71.0M +91.58% | 37.1M +133.75% | |
Sales and Marketing Expense | 228.8M +33.48% | 171.4M +30.08% | 131.8M +48.35% | 88.8M +74.05% | |
Research and Development Expense | -71.3M +14.41% | -62.3M +28.59% | -48.4M +67.16% | -29.0M +52.59% | |
Depreciation and Amortization Expense | 6.4M +22.09% | 5.2M +37.48% | 3.8M +34.00% | 2.8M -14.53% | |
Total Operating Expenses | 300.1M +28.40% | 233.7M +29.68% | 180.2M +52.98% | 117.8M +68.23% | |
Operating Profit | -103.9M +7.50% | -96.6M -11.50% | -109.2M +35.24% | -80.7M +49.04% | |
Interest Income | 12.2M +12.15% | 10.9M +44.29% | 7.6M +202.40% | 2.5M +3,185.53% | |
Interest Expense | N/A N/A | N/A N/A | -4.0M -22.92% | -5.2M -10.79% | |
Interest Income and Expense and Net | 12.2M +12.15% | 10.9M +206.38% | 3.6M +232.39% | -2.7M -53.16% | |
Total Nonoperating Income and Expense | -156,000 -88.83% | -1.4M -134.94% | 4.0M -22.92% | 5.2M -10.79% | |
Income before Taxes | -95.4M -1.28% | -96.6M -11.50% | -109.2M +35.24% | -80.7M +49.04% | |
Income Taxes | 190,000 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -95.6M +4.55% | -91.4M -13.68% | -105.9M +21.51% | -87.2M +45.61% | |
Net Income from Continuing Operations Applicable to Common | -95.4M +4.34% | -91.4M -13.68% | -105.9M +21.51% | -87.2M +45.61% | |
Basic EPS and Net Income | -1.72 -1.71% | -1.75 -21.87% | -2.24 +14.29% | -1.96 -46.01% | |
Diluted EPS and Net Income | -1.72 -1.71% | -1.75 -21.87% | -2.24 +14.29% | -1.96 -46.01% | |
Basic Weighted Average Shares | 55.5M +6.56% | 52.1M +10.31% | 47.3M +6.43% | 44.4M +169.42% | |
Diluted Weighted Average Shares | 55.5M +6.56% | 52.1M +10.31% | 47.3M +6.43% | 44.4M +169.42% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 286.5M -14.15% | 333.7M +29.74% | 257.2M +15.94% | 221.9M -27.10% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 286.5M -14.15% | 333.7M +29.74% | 257.2M +15.94% | 221.9M -27.10% | |
Total Current Assets | 450.4M -6.53% | 481.8M +37.45% | 350.6M +28.59% | 272.6M -16.42% | |
Accumulated Depreciation | 12.8M +62.86% | 7.8M +113.41% | 3.7M -59.25% | 9.0M +34.51% | |
Property and Plant and Equipment and Net | 30.4M +13.82% | 26.7M -7.09% | 28.7M +232.12% | 8.7M +71.58% | |
Total Long-Term Assets | 6.0M +135.58% | 2.6M +178.02% | 919,000 +1,701.96% | 51,000 -98.99% | |
Total Assets | 508.1M -4.86% | 534.0M +31.95% | 404.7M +30.84% | 309.3M -8.22% | |
Income Taxes Payable | 1.5M -29.50% | 2.1M +19.88% | 1.7M +108.08% | 829,000 +60.97% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 65.8M +23.83% | 53.1M +15.69% | 45.9M +30.14% | 35.3M +117.28% | |
Total Long-Term Debt | 51.6M +0.28% | 51.5M +0.26% | 51.3M +0.25% | 51.2M +2.42% | |
Total Long-Term Liabilities | 147,000 -54.63% | 324,000 -37.33% | 517,000 N/A | 0 -100.00% | |
Total Liabilities | 142.2M +7.90% | 131.8M +6.32% | 124.0M +10.43% | 112.3M +60.52% | |
Retained Earnings | -641.6M +17.50% | -546.0M +20.11% | -454.6M +30.37% | -348.7M +33.33% | |
Total Stockholders Equity | 365.9M -9.04% | 402.2M +43.27% | 280.8M +42.46% | 197.1M -26.22% | |
Total Shares Outstanding | 56.3M +10.94% | 50.8M 0.00% | 50.8M +13.26% | 44.8M +2.64% | |
Cash Flow | |||||
Cash from Operating Activities | -49.0M -50.63% | -99.2M -8.14% | -108.0M +34.36% | -80.4M +40.20% | |
Capital Expenditures | 9.4M +112.20% | 4.4M -82.51% | 25.2M +850.09% | 2.7M +348.14% | |
Cash from Investing Activities | -9.4M +112.20% | -4.4M -82.51% | -25.2M +850.09% | -2.7M +348.14% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 11.2M -93.79% | 180.1M +7.35% | 167.8M +4,545.49% | 3.6M -98.62% | |
Financials Ratio | |||||
Gross Margin | 63.70% +4.31% | 61.07% +17.06% | 52.17% +5.52% | 49.44% N/A | |
Operating Margin | -33.71% -21.66% | -43.04% -46.31% | -80.16% -25.51% | -107.61% N/A | |
Return on Assets | -18.34% -5.82% | -19.48% -34.34% | -29.66% +9.99% | -26.97% N/A | |
Return on Equity | -24.89% -7.04% | -26.77% -39.61% | -44.32% +18.03% | -37.55% N/A | |
Revenue Growth | 37.22% -42.60% | 64.84% -20.49% | 81.55% -30.65% | 117.60% N/A | |
Current Ratio | 6.85 -24.52% | 9.07 +18.81% | 7.63 -1.19% | 7.73 N/A | |
Cash Ratio | 4.35 -30.67% | 6.28 +12.14% | 5.60 -10.91% | 6.29 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow